Owens & Minor, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US6907321029
USD
2.55
-0.05 (-1.92%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1158711,
    "name": "Owens & Minor, Inc.",
    "stock_name": "Owens & Minor, Inc.",
    "full_name": "Owens & Minor, Inc.",
    "name_url": "stocks-analysis/owens-minor-inc",
    "exchange": 207,
    "exchangecode": "NYS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "2.55",
    "chg": -0.05,
    "chgp": "-1.92%",
    "dir": -1,
    "prev_price": "2.60",
    "mcapval": "415.57",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2325,
    "indexname": "S&P 500",
    "isin": "US6907321029",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "4.76 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/owens-minor-inc-1158711-207&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Owens & Minor, Inc. Hits New 52-Week Low at $3.76",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/owens-minor-inc-hits-new-52-week-low-at-376-3667236",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/OwensMinorInc_priceRelatedfactors_3667236.png",
        "date": "2025-11-03 16:58:54",
        "description": "Owens & Minor, Inc. has reached a new 52-week low, reflecting significant challenges within the company. With a market capitalization of USD 416 million, it shows troubling financial metrics, including a negative return on equity and high debt levels, raising concerns about its long-term viability in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Owens & Minor, Inc. Hits New 52-Week Low at $4.35",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/owens-minor-inc-hits-new-52-week-low-at-435-3617579",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/OwensMinorInc_priceRelatedfactors_3617579.png",
        "date": "2025-10-13 17:27:39",
        "description": "Owens & Minor, Inc. has hit a new 52-week low, reflecting a challenging year with a significant stock price decline. Financial metrics show a low P/E ratio and concerning indicators such as negative Return on Equity and a high Debt to Equity ratio, highlighting ongoing valuation and profitability issues."
      },
      {
        "title": "Is Owens & Minor, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-owens-minor-inc-technically-bullish-or-bearish-3545282",
        "imagepath": "",
        "date": "2025-09-20 19:07:58",
        "description": "As of 5 August 2025, the technical trend for Owens & Minor, Inc. has changed from mildly bearish to bearish. The current technical stance is bearish, with key indicators supporting this view including bearish MACD readings on both the weekly and monthly charts, bearish moving averages on the daily timeframe, and a bearish KST on both weekly and monthly periods. Additionally, the Bollinger Bands and OBV are showing mildly bearish signals. \n\nIn terms of performance, the stock has significantly underperformed compared to the S&P 500, with a year-to-date return of -57.54% versus the S&P 500's 12.22%, and a one-year return of -64.90% compared to 17.14% for the benchmark...."
      },
      {
        "title": "Is Owens & Minor, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-owens-minor-inc-overvalued-or-undervalued-3541998",
        "imagepath": "",
        "date": "2025-09-20 17:41:52",
        "description": "As of 5 May 2023, the valuation grade for Owens & Minor, Inc. has moved from expensive to risky, indicating a shift in perception regarding its market value. The company appears to be overvalued based on its current metrics, with a P/E ratio of 6, an EV to EBITDA of 4.76, and a PEG ratio of 0.14, which suggests limited growth prospects relative to its price. In comparison to peers, Owens & Minor has a higher P/E ratio than Pacific Biosciences of California, Inc., which has a P/E of -0.6779, highlighting a relative overvaluation.\n\nThe stock has significantly underperformed against the S&P 500, with a year-to-date return of -57.54% compared to the index's 12.22%. This stark contrast reinforces the notion that Owens & Minor, Inc. is currently overvalued in the market...."
      }
    ],
    "total": 9,
    "sid": "1158711",
    "stock_news_url": "https://www.marketsmojo.com/news/owens-minor-inc-1158711"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}
stock newsNews and Views
stock-recommendationAnnouncement
Icon
No announcement available
stock-recommendationCorporate Actions
Corporate Actions
info
Icon
No corporate action available